(Q46690670)

24 December 2017

title

Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats (English)

1 reference

24 December 2017

author name string

David J Leehey

1

1 reference

24 December 2017

Ashok K Singh

2

1 reference

24 December 2017

Joseph P Bast

3

1 reference

24 December 2017

Periannan Sethupathi

4

1 reference

24 December 2017

Rekha Singh

5

1 reference

24 December 2017

publication date

12 February 2008

1 reference

24 December 2017

published in

Translational Research

1 reference

24 December 2017

volume

151

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

208-216

1 reference

24 December 2017

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2008.01.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2008.01.003

1 reference

24 December 2017

1 reference

24 December 2017